Vyant Bio, Inc.
VYNT
OTC PK
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -1.63M | -4.48M | -4.26M | -3.46M | -5.81M |
| Total Depreciation and Amortization | 87.00K | 193.00K | 198.00K | 198.00K | 207.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 133.00K | 134.00K | 709.00K | 354.00K | 1.64M |
| Change in Net Operating Assets | -404.00K | -1.46M | 60.00K | 657.00K | -203.00K |
| Cash from Operations | -1.81M | -5.61M | -3.29M | -2.25M | -4.16M |
| Capital Expenditure | -- | -- | -9.00K | -247.00K | -331.00K |
| Sale of Property, Plant, and Equipment | 0.00 | 190.00K | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | -132.00K | 3.96M | -4.00K | 30.00K |
| Cash from Investing | 0.00 | 58.00K | 3.95M | -251.00K | -301.00K |
| Total Debt Issued | -- | -- | 0.00 | 266.00K | -- |
| Total Debt Repaid | -253.00K | -89.00K | -60.00K | -59.00K | -38.00K |
| Issuance of Common Stock | 0.00 | 458.00K | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 52.00K | -10.00K | -164.00K |
| Cash from Financing | -253.00K | 369.00K | -8.00K | 197.00K | -202.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -72.00K |
| Net Change in Cash | -2.06M | -5.18M | 647.00K | -2.31M | -4.74M |